INVEGA® (paliperidone) extended-release tablets are indicated for the treatment of schizophrenia in adults and adolescents (12-17 years of age).
The efficacy of INVEGA® in schizophrenia was established in three 6-week trials in adults and one 6-week trial in adolescents (12-17 years of age), as well as one maintenance trial in adults.
INVEGA® (paliperidone) extended-release tablets are indicated for the treatment of schizoaffective disorder as monotherapy and as an adjunct to mood stabilizers and/or antidepressant therapy in adults.
The efficacy of INVEGA® in schizoaffective disorder was established in two 6-week trials in adults.
Paliperidone is a medication that works in the brain to treat schizophrenia and schizoaffective disorder.
It is also known as a second-generation antipsychotic (SGA) or atypical antipsychotic.
Paliperidone rebalances dopamine and serotonin to improve thinking, mood, and behavior.
Paliperidone extended-release tablets are indicated for the treatment of schizoaffective disorder as monotherapy and as an adjunct to mood stabilizers and/or antidepressant therapy in adults and for the treatment of schizophrenia in adults.
How To Use:
Paliperidone tablets are usually taken 1 time per day with or without food.
Typically patients begin at a low dose of medicine and the dose is increased slowly over several weeks.
The dose of the tablets usually ranges from 3 mg to 12 mg.
Only your healthcare provider can determine the correct dose for you.
The tablets should be swallowed whole.
They should not be chewed, crushed, or broken.
Use a calendar, pillbox, alarm clock, or cell phone alert to help you remember to take your medication.
You may also ask a family member or a friend to remind you or check in with you to be sure you are taking your medication.
Warnings And Precautions:
INVEGA® and similar medicines can raise the blood levels of a hormone called prolactin, and blood levels of prolactin remain high with continued use.
This may result in some side effects, including missed menstrual periods, leakage of milk from the breasts, development of breasts in men, or problems with erection.
People with narrowing or blockage of the gastrointestinal tract (esophagus, stomach, or small or large intestine) should talk to their healthcare professional before taking INVEGA®.
Some people taking INVEGA® may feel faint or lightheaded when they stand up or sit up too quickly. By standing up or sitting up slowly and following your healthcare professional's dosing instructions, this side effect may be reduced.
Patients (particularly the elderly) taking antipsychotics with certain health conditions or those on long-term therapy should be evaluated by their healthcare provider for the potential risk of falls.
Blood problems such as low numbers of white blood cells have been reported in patients taking INVEGA® and similar medications.
In some cases it has been serious and life-threatening. Depending upon your medical condition, your healthcare professional may choose to test your blood as you start therapy with INVEGA®.
INVEGA® may affect your ability to make decisions, think clearly, or react quickly. Do not drive, operate heavy machinery, or do other dangerous activities until you know how INVEGA® affects you.
INVEGA® should be used cautiously in people with a seizure disorder, who have had seizures in the past, or who have conditions that increase their risk for seizures.
INVEGA® may increase difficulty in swallowing that may cause food or liquid to get into your lungs.
Paliperidone Extended-Release Tablets:
15 Mg,3 Mg,6 Mg,9 Mg